{"id":70711,"date":"2026-05-12T09:38:54","date_gmt":"2026-05-12T09:38:54","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70711"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"dsip","status":"publish","type":"product","link":"https:\/\/medsbase.com\/de\/product\/dsip\/","title":{"rendered":"DSIP"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Kurze Antwort \u2014 Was ist DSIP?<\/h3>\n<p style=\"margin: 0;\"><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide first isolated from rabbit cerebral venous blood during electrical stimulation of thalamic sleep-promoting regions in 1977. In published studies it modulates sleep architecture \u2014 specifically slow-wave (delta) sleep \u2014 alongside documented effects on stress reactivity, withdrawal syndromes, and nociception. Supplied in 5\u00a0mg to 15\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Was Sie bei MedsBase erhalten:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/de\/reviews\/\">Kundenbewertungen<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Jede Bestellung ist durch unsere <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> abgedeckt \u2014 wenn Ihr Paket nicht innerhalb von 20 Werktagen ankommt, versenden wir es erneut.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Spezifikation<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS-Nummer<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">62568-57-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekularformel<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Molekulargewicht<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">848,81 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE, 9 Aminos\u00e4uren; linear, unmodifizierte Termini)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Form<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat (wei\u00df bis leicht gelblich)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Reinheit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC-best\u00e4tigt, COA auf Anfrage)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Lagerung<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilisat: 2\u20138 \u00b0C (K\u00fchlschrank) f\u00fcr Arbeitsvorrat; \u221220 \u00b0C zur Langzeitlagerung unge\u00f6ffneter Fl\u00e4schchen. Rekonstituiert: 2\u20138 \u00b0C, innerhalb von ~30 Tagen verwenden. Vor Licht sch\u00fctzen. Die rekonstituierte L\u00f6sung nicht einfrieren und auftauen.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>L\u00f6slichkeit<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bakteriostatisches Wasser (empfohlen) oder steriles Wasser f\u00fcr k\u00fcrzere Anwendungszeitr\u00e4ume<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Was ist DSIP?<\/h2>\n<p><strong>DSIP<\/strong> (Delta Sleep-Inducing Peptide) is a 9-amino-acid linear neuropeptide first isolated by Schoenenberger and Monnier at the University of Basel in 1977. The peptide was identified by dialysing cerebral venous blood from rabbits during electrical stimulation of the intralaminar thalamus \u2014 a region known to drive delta-wave (slow-wave) sleep in the cortex \u2014 and concentrating the bioactive fraction. DSIP was named for the dominant electroencephalographic signature it produced when administered to recipient animals: increased proportion of delta-wave activity during sleep. The well-characterised sequence is WAGGDASGE, molecular weight 848.81\u00a0Da, empirical formula C<sub>35<\/sub>H<sub>48<\/sub>N<sub>10<\/sub>O<sub>15<\/sub>. DSIP ist strukturell ungew\u00f6hnlich unter kleinen ZNS-aktiven Peptiden \u2013 es ist linear, an beiden Termini unmodifiziert und enth\u00e4lt keine Prolin- oder Cysteinreste. Das Peptid wird als hochreines lyophilisiertes Pulver zur Rekonstitution mit bakterienstatischem Wasser geliefert. DSIP ist <strong>nicht zugelassen<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For related circadian and sleep-axis peptide studies, see our <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> und <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> Produktseiten. <\/p>\n<h2>Wirkmechanismus \u2013 Schlafarchitektur, Stressreaktivit\u00e4t und Neuroprotektion<\/h2>\n<p>What makes DSIP unusual among peptides is the breadth of effects documented for such a small, linear peptide without a clearly identified primary receptor. Published studies has mapped its activity across <strong>drei \u00fcberlappende Wirkbereiche<\/strong>, die jeweils zum beobachteten Ph\u00e4notyp beitragen:<\/p>\n<ul>\n<li><strong>Modulation der Schlafarchitektur \u2014 Delta-Wellen-Schlaf (Slow-Wave-Schlaf)<\/strong> \u2014 DSIP increases the proportion of slow-wave (stage 3\u20134 \/ N3) sleep on quantitative EEG measurements in rodent, rabbit, and human studies without proportionally reducing REM sleep. The effect is most pronounced when DSIP is administered to subjects with fragmented or shortened sleep, suggesting the peptide acts as a homeostatic sleep-pressure modulator rather than a primary sedative. Importantly, DSIP does not directly increase total sleep time in non-sleep-deprived subjects \u2014 it reorganises sleep architecture toward higher SWS proportion.<\/li>\n<li><strong>Modulation der HPA-Achse und Stressreaktivit\u00e4t<\/strong> \u2014 Mehrere publizierte Studien belegen eine Abschw\u00e4chung der stressinduzierten Cortisol- und ACTH-Aussch\u00fcttung in Nagetiermodellen mit Restraint-Stress, ebenso wie eine Reduktion der Corticotropin-releasing-Hormon (CRH)-Signalgebung im Hypothalamus. Der stresspuffernde Effekt wirkt \u00fcber einen l\u00e4ngeren Zeitraum als Benzodiazepin-Sedativa und erzeugt keine akute behaviorale Sedierung, was auf eine Modulation des HPA-Achsen-Tonus hindeutet und nicht auf eine akute Anxiolyse.<\/li>\n<li><strong>Antinozizeption, Neuroprotektion und Anti-Entzug<\/strong> \u2014 DSIP shows analgesic effects in rodent thermal and chemical-nociception models, including opioid-naive subjects (suggesting non-opioid mechanism). Russian and Eastern European has documented attenuation of opioid and alcohol withdrawal syndromes in preclinical models. Neuroprotective effects against oxidative stress, ischaemia, and excitotoxicity have been reported but remain mechanistically less well characterised than the sleep architecture work.<\/li>\n<\/ul>\n<p>The receptor target for DSIP has not been definitively identified, which is unusual for a peptide with this much published behavioural data. Proposed mechanisms include GABA-A modulation, opioid-system crosstalk, and direct interaction with hypothalamic CRH neurons. The lack of an identified primary receptor combined with multiple documented effects suggests DSIP may act as a multimodal neuromodulator rather than a classical receptor agonist \u2014 a hypothesis that remains an active studies question in published peptide pharmacology. <\/p>\n<h2>Published Evidence<\/h2>\n<p>DSIP is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Sleep architecture and EEG studies<\/strong> \u2014 quantitative EEG spectral analysis, slow-wave sleep proportion, sleep fragmentation in rodent and human studies (Schoenenberger &amp; Monnier, PNAS 1977; Kovalzon &amp; Strekalova, Sleep Med Rev 2006)<\/li>\n<li><strong>Stress reactivity and HPA-axis studies<\/strong> \u2014 Cortisol- und ACTH-Dynamik, CRH-Expression, Restraint-Stress- und Chronic-Mild-Stress-Modelle bei Nagetieren<\/li>\n<li><strong>Withdrawal syndrome studies<\/strong> \u2014 Opioidentzugsschwere, Alkoholentzug, Benzodiazepin-Ausschleichung; \u00fcberwiegend russische und osteurop\u00e4ische Fachliteratur<\/li>\n<li><strong>Nociception and chronic pain studies<\/strong> \u2014 Schwanzflick-, Heizplatten-, Formalin- und chronische Konstriktionsverletzungsmodelle bei Nagetieren; Charakterisierung nicht-opioider Mechanismen<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 oxidative Stressmarker, Isch\u00e4mie-Reperfusionssch\u00e4den, Exzitotoxizit\u00e4tsmodelle<\/li>\n<li><strong>Circadian biology studies<\/strong> \u2014 Synchronisation, Phasenverschiebungsreaktion, Modulation von Melatonin- und Kerntemperaturrhythmen<\/li>\n<li><strong>Comparative sleep-axis peptide studies<\/strong> \u2014 Benchmarking gegen <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> (Pineal-Tetrapeptid) f\u00fcr zirkadiane Effekte und gegen <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> f\u00fcr stresspuffernde Effekte ohne Sedierung.<\/li>\n<\/ul>\n<p>F\u00fcr einen breiteren Kontext, wo DSIP in die Landschaft der kleinen ZNS-aktiven Peptide passt, siehe <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> (AEDG pineal tetrapeptide, circadian-axis studies), <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> (anxiolytisches Heptapeptid), und <a href=\"https:\/\/medsbase.com\/de\/semax\/\">Semax<\/a> (nootropes Heptapeptid). Durchsuchen Sie das vollst\u00e4ndige <a href=\"https:\/\/medsbase.com\/de\/peptides\/\">Peptid-Katalog<\/a> f\u00fcr verwandte Verbindungen. <\/p>\n<h2>Verf\u00fcgbare St\u00e4rken und Konzentrationen<\/h2>\n<p>MedsBase stocks DSIP in three lyophilized vial sizes covering pilot dosing through extended protocols. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Vial-St\u00e4rke<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Typischer Anwendungsfall<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Packungsgr\u00f6\u00dfen<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, single-EEG-session studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, multi-week sleep-architecture studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>15 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protokolle mit verl\u00e4ngertem Zyklus, niedrigste Kosten pro mg, Multikohortenstudien<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 oder 30 Vials<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols or run extended studies from a single vial. <\/p>\n<h2>Vergleich \u2014 DSIP vs. Epitalon<\/h2>\n<p>DSIP und <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> are the two most-cited small peptides involved in sleep, circadian, and rest-state studies. They share several studies-relevant features \u2014 both are short, linear, unmodified peptides without identified primary receptors, and both produce phenotypic effects that outlast plasma clearance \u2014 but their primary signals are distinct: DSIP modulates sleep architecture directly via SWS proportion; Epitalon acts on the pineal-melatonin axis and circadian gene expression. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Kriterium<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">DSIP<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>L\u00e4nge<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 Aminos\u00e4uren (linear)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 Aminos\u00e4uren (Tetrapeptid)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequenz<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">WAGGDASGE<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">AEDG (Ala-Glu-Asp-Gly)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Slow-Wave-Schlaf-Anteil (EEG-Delta)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pineal-Melatonin-Achse, Telomerase, zirkadiane Genexpression<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Identifizierter Rezeptor<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Keiner (multimodaler Neuromodulator)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Keiner (genregulatorisch, intrazellul\u00e4r)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typische Dosis<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100\u2013500 mcg, 1x t\u00e4glich<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg, 1x t\u00e4glich f\u00fcr Zyklen<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Wirkungseintritt<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Innerhalb derselben Sitzung (EEG-messbar)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mehrw\u00f6chig (Zeitskala der Genexpression)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stacking<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Co-administered with Epitalon in circadian-sleep stack studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">In Kombination mit DSIP f\u00fcr kombinierte Schlaf- und zirkadiane Effekte<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For sleep-architecture studies, DSIP is the canonical first choice because it produces measurable EEG-level effects on slow-wave sleep proportion within a single sleep session. For circadian-rhythm and gene-regulatory studies, Epitalon is preferred because the effect timescale matches the underlying biology (gene expression changes over days to weeks). The two are frequently co-administered when both axes are part of the studies question. <\/p>\n<h2>Lagerung und Rekonstitution<\/h2>\n<p><strong>Vor der Rekonstitution:<\/strong> Lyophilisierte Fl\u00e4schchen f\u00fcr den kurzfristigen Gebrauch im Originalbeh\u00e4lter bei 2\u20138 \u00b0C k\u00fchl lagern. F\u00fcr unge\u00f6ffnete Langzeitlagerung bei \u221220 \u00b0C einfrieren. Lyophilisiertes DSIP ist unter K\u00fchlung bis zu 24 Monate und bei \u221220 \u00b0C bis zu 36 Monate stabil. Vermeiden Sie Gefrier-Tau-Zyklen des lyophilisierten Pulvers. DSIP ist hygroskopisch \u2013 Fl\u00e4schchen nach dem \u00d6ffnen umgehend wieder verschlie\u00dfen und wenn m\u00f6glich in einem Exsikkator aufbewahren. <strong>Rekonstitutionsverfahren:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 2.0\u00a0mL of bacteriostatic water yields a 2.5\u00a0mg\/mL working concentration \u2014 0.04\u00a0mL delivers a 100\u00a0mcg dose. Swirl gently \u2014 do <strong>nicht<\/strong> Sch\u00fctteln Sie \u2014 und lassen Sie 2\u20135 Minuten f\u00fcr die vollst\u00e4ndige Aufl\u00f6sung. Eine korrekt rekonstituierte L\u00f6sung sollte klar und farblos sein. <strong>gek\u00fchlt bei 2\u20138 \u00b0C lagern und innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren.<\/strong> Rekonstituierte L\u00f6sung bei 2\u20138 \u00b0C k\u00fchl lagern und innerhalb von 30 Tagen f\u00fcr optimale Stabilit\u00e4t verwenden. Die rekonstituierte L\u00f6sung nicht einfrieren \u2013 Gefrier-Tau-Zyklen beeintr\u00e4chtigen die Peptidintegrit\u00e4t. Fl\u00e4schchen mit Tr\u00fcbung, Ausf\u00e4llung oder Verf\u00e4rbung verwerfen. <\/p>\n<h2 id=\"faqs\">H\u00e4ufig gestellte Fragen<\/h2>\n<h3>What is DSIP used for in studies?<\/h3>\n<p>DSIP is used in studies investigating sleep architecture (particularly slow-wave sleep proportion), HPA-axis and stress reactivity, opioid and alcohol withdrawal syndromes, non-opioid analgesia, neuroprotection, and circadian biology. It is the most-cited sleep-axis peptide that does not act primarily as a sedative \u2014 effects manifest as reorganisation of sleep architecture rather than increased total sleep time. The pharmaceutical-grade DSIP sold here is <strong>nicht<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>Wie unterscheidet sich DSIP von Epitalon?<\/h3>\n<p>Both are small unmodified peptides without identified primary receptors that influence rest-state biology, but their primary signals differ. DSIP modulates sleep architecture at the EEG level \u2014 specifically increasing slow-wave sleep proportion within a single sleep session. Epitalon acts on the pineal-melatonin axis and circadian gene expression on a gene-expression timescale of days to weeks. The two are mechanistically complementary and frequently co-administered in studies investigating combined sleep and circadian endpoints. <\/p>\n<h3>What is the typical DSIP dose?<\/h3>\n<p>Ver\u00f6ffentlichte pr\u00e4klinische Protokolle verwenden typischerweise 100\u2013500 \u00b5g pro Verabreichung in Nagetiermodellen, subkutan oder intraperitoneal einmal t\u00e4glich f\u00fcr 7\u201328 Tage. Eine 5 mg-Vial, rekonstituiert mit 2,0 mL bakterizidem Wasser, ergibt 2,5 mg\/mL \u2013 0,04 mL entsprechen 100 \u00b5g. <\/p>\n<h3>Ist DSIP von der FDA zugelassen?<\/h3>\n<p>No. DSIP is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h3>Wie sollte DSIP gelagert werden?<\/h3>\n<p>Lyophilisierte Vials: kurzzeitig gek\u00fchlt bei 2\u20138 \u00b0C als Arbeitsvorrat oder bei \u221220 \u00b0C zur Langzeitlagerung unge\u00f6ffneter Vials. DSIP ist hygroskopisch \u2013 Vials nach dem \u00d6ffnen umgehend wieder verschlie\u00dfen. Rekonstituierte L\u00f6sung: gek\u00fchlt bei 2\u20138 \u00b0C, innerhalb von 30 Tagen verwenden. Rekonstituierte L\u00f6sung nicht einfrieren \u2013 Gefrier-Tau-Zyklen degradieren das Peptid. Immer vor direktem Licht sch\u00fctzen. <\/p>\n<h3>Wie rekonstituiere ich DSIP?<\/h3>\n<p>Befolgen Sie das oben beschriebene Rekonstitutionsverfahren. Geben Sie bakterienstatisches Wasser an der Seitenwand des Fl\u00e4schchens hinzu (nicht auf den lyophilisierten Kuchen), schwenken Sie vorsichtig und lassen Sie 2\u20135 Minuten zur vollst\u00e4ndigen Aufl\u00f6sung. Sch\u00fctteln Sie <strong>nicht<\/strong> das Fl\u00e4schchen nicht. Eine korrekt rekonstituierte L\u00f6sung ist klar und farblos. F\u00fcr ein 5 mg-Fl\u00e4schchen + 2,0 mL Verd\u00fcnnungsmittel betr\u00e4gt die Arbeitskonzentration 2,5 mg\/mL. <\/p>\n<h3>Welche St\u00e4rken f\u00fchrt MedsBase?<\/h3>\n<p>MedsBase carries DSIP in 5\u00a0mg, 10\u00a0mg, and 15\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Does DSIP cause sedation in study models?<\/h3>\n<p>No \u2014 this is one of the most-cited findings in DSIP studies. Unlike benzodiazepines or other classical sedatives, DSIP does not produce acute behavioural sedation, motor coordination loss, or impaired alertness. Instead it modulates sleep architecture toward a higher proportion of slow-wave sleep when the subject does sleep, without increasing total sleep time in non-sleep-deprived subjects. This distinct profile is one of the reasons DSIP has remained a compound rather than a clinical sedative. <\/p>\n<h3>Can DSIP and Epitalon be stacked in studies?<\/h3>\n<p>Yes. DSIP and Epitalon act on different timescales and biological compartments (acute EEG-level sleep architecture vs gene-expression-level circadian regulation), so co-administration is not pharmacologically redundant. Study protocols studying combined sleep-quality and circadian-rhythm endpoints frequently use both peptides. <\/p>\n<h3>Does DSIP cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation. Long-term human safety data is limited because the peptide has not undergone modern Western regulatory review. The small size and lack of identified primary receptor are consistent with the clean tolerability profile. <\/p>\n<h3>Wie lang ist die Halbwertszeit von DSIP?<\/h3>\n<p>In preclinical studies, DSIP has a plasma half-life of approximately 7\u201315 minutes following intravenous or subcutaneous administration. The short plasma half-life is offset by the peptide&#8217;s ability to cross the blood-brain barrier and produce effects on sleep architecture and gene expression that persist well beyond plasma clearance. <\/p>\n<h3>Warum wurde DSIP urspr\u00fcnglich isoliert?<\/h3>\n<p>DSIP wurde 1977 von Schoenenberger und Monnier an der Universit\u00e4t Basel identifiziert, indem sie zerebrales ven\u00f6ses Blut von Kaninchen w\u00e4hrend elektrischer Stimulation des intralaminaren Thalamus dialysierten \u2013 einer Gehirnregion, die f\u00fcr Delta-Wellen (Slow-Wave-Schlaf) bekannt ist. Sie konzentrierten die bioaktive Fraktion und charakterisierten das Peptid, das den st\u00e4rksten Schlaf-EEG-Effekt bei der \u00dcbertragung auf Empf\u00e4ngertiere zeigte. Das Peptid wurde nach seinem dominanten elektroenzephalographischen Signal benannt: erh\u00f6hte Delta-Wellen-Aktivit\u00e4t w\u00e4hrend des Schlafs. <\/p>\n<h3>How long does DSIP take to show effects in preclinical studies?<\/h3>\n<p>Akute Effekte auf die Schlafarchitektur und den Delta-Wellen-Anteil im EEG sind innerhalb der ersten Schlafphase nach der Verabreichung nachweisbar. Effekte auf die HPA-Achse und die Stressreaktivit\u00e4t akkumulieren \u00fcber 7\u201314 Tage regelm\u00e4\u00dfiger Dosierung. Anti-Entzugseffekte in Opioid- und Alkoholentzugsmodellen werden typischerweise \u00fcber 3\u20137-t\u00e4gige Entzugsperioden gemessen. <\/p>\n<h3>Kann ich DSIP f\u00fcr den internationalen Versand bestellen?<\/h3>\n<p>Ja. MedsBase versendet DSIP weltweit \u00fcber unser spezielles Peptid-Versandnetzwerk. Bestellungen, die ausschlie\u00dflich Peptide enthalten, qualifizieren sich f\u00fcr unseren eigenst\u00e4ndigen Peptid-Versandservice. Alle Bestellungen werden in temperaturkontrollierter Verpackung mit vollst\u00e4ndiger Sendungsverfolgung versandt und sind abgedeckt durch unser <a href=\"https:\/\/medsbase.com\/de\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Sleep, Circadian, and CNS Studies<\/h2>\n<ul>\n<li><a href=\"\/de\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 pineal-melatonin axis and circadian gene-expression studies<\/li>\n<li><a href=\"\/de\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/de\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Russisch entwickeltes nootropes Heptapeptid \u2014 Melanocortin- und dopaminerge Modulation<\/li>\n<li><a href=\"\/de\/oxytocin-acetate\/\"><strong>Oxytocin Acetat<\/strong><\/a> \u2014 9-aa cyclic nonapeptide \u2014 social-bonding and affiliative behavioural support<\/li>\n<li><a href=\"\/de\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 healing and tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Weiterf\u00fchrende Literatur<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore sleep, circadian, and CNS peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Durchst\u00f6bern Sie das gesamte Sortiment <a href=\"https:\/\/medsbase.com\/de\/peptides\/\"><strong>Peptid-Katalog<\/strong><\/a>, mit verwandten Verbindungen einschlie\u00dflich <a href=\"https:\/\/medsbase.com\/de\/epitalon\/\">Epitalon<\/a> for circadian gene-expression studies, <a href=\"https:\/\/medsbase.com\/de\/selank\/\">Selank<\/a> for anxiolytic stress-axis studies, and <a href=\"https:\/\/medsbase.com\/de\/oxytocin-acetate\/\">Oxytocin Acetat<\/a> for social-bonding behavioural support.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Delta-Schlaf-induzierendes Peptid (Entdeckung 1977)<br \/>\n\u2705 Moduliert die Architektur des Slow-Wave-Schlafs<br \/>\n\u2705 HPA-axis stress reactivity<br \/>\n\u2705 Anti-Entzugs- und nicht-opioide Analgesie<br \/>\n\u2705 \u00dcberwindet die Blut-Hirn-Schranke<\/p>\n<p><strong>DSIP<\/strong> enth\u00e4lt synthetische Peptidverbindung.<\/p>","protected":false},"featured_media":70946,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6275,5441],"class_list":["post-70711","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-dsip","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product\/70711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/comments?post=70711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media\/70946"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/media?parent=70711"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_brand?post=70711"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_cat?post=70711"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/de\/wp-json\/wp\/v2\/product_tag?post=70711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}